These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35598675)

  • 1. Immune-related biomarkers for Parkinson's disease.
    Abdi IY; Ghanem SS; El-Agnaf OM
    Neurobiol Dis; 2022 Aug; 170():105771. PubMed ID: 35598675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into Neuroinflammation in Parkinson's Disease: From Biomarkers to Anti-Inflammatory Based Therapies.
    Rocha NP; de Miranda AS; Teixeira AL
    Biomed Res Int; 2015; 2015():628192. PubMed ID: 26295044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory Mechanisms in Parkinson's Disease: From Pathogenesis to Targeted Therapies.
    Lee SYH; Yates NJ; Tye SJ
    Neuroscientist; 2022 Oct; 28(5):485-506. PubMed ID: 33586516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of chemokines in Parkinson's disease.
    Liu JQ; Chu SF; Zhou X; Zhang DY; Chen NH
    Brain Res Bull; 2019 Oct; 152():11-18. PubMed ID: 31136787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum immune markers and disease progression in an incident Parkinson's disease cohort (ICICLE-PD).
    Williams-Gray CH; Wijeyekoon R; Yarnall AJ; Lawson RA; Breen DP; Evans JR; Cummins GA; Duncan GW; Khoo TK; Burn DJ; Barker RA;
    Mov Disord; 2016 Jul; 31(7):995-1003. PubMed ID: 26999434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene Dysfunction Mediates Immune Response to Dopaminergic Degeneration in Parkinson's Disease.
    Jiao Z; Zhang W; Chen C; Zhu X; Chen X; Zhou M; Peng G; Liu H; Qiu J; Lin Y; Huang S; Mo M; Yang X; Qu S; Xu P
    ACS Chem Neurosci; 2019 Feb; 10(2):803-811. PubMed ID: 30289236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenetic Determinants of Parkinson's Disease Etiology.
    Kung PJ; Elsayed I; Reyes-Pérez P; Bandres-Ciga S
    J Parkinsons Dis; 2022; 12(s1):S13-S27. PubMed ID: 35367971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parkinson's disease: Autoimmunity and neuroinflammation.
    De Virgilio A; Greco A; Fabbrini G; Inghilleri M; Rizzo MI; Gallo A; Conte M; Rosato C; Ciniglio Appiani M; de Vincentiis M
    Autoimmun Rev; 2016 Oct; 15(10):1005-11. PubMed ID: 27497913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similarity and Differences in Inflammation-Related Characteristics of the Peripheral Immune System of Patients with Parkinson's and Alzheimer's Diseases.
    Boyko AA; Troyanova NI; Kovalenko EI; Sapozhnikov AM
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29211044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression characteristics of peripheral blood genes reveal potential biomarkers and candidate therapeutic targets for Parkinson's disease.
    Chen W; Zhou D; Zhu N; Yan X; Jiang G; Zhao L
    Cell Mol Biol (Noisy-le-grand); 2020 May; 66(2):118-124. PubMed ID: 32415937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA damage and repair in Parkinson's disease: Recent advances and new opportunities.
    Gonzalez-Hunt CP; Sanders LH
    J Neurosci Res; 2021 Jan; 99(1):180-189. PubMed ID: 32048327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is Parkinson's disease a chronic low-grade inflammatory bowel disease?
    Rolli-Derkinderen M; Leclair-Visonneau L; Bourreille A; Coron E; Neunlist M; Derkinderen P
    J Neurol; 2020 Aug; 267(8):2207-2213. PubMed ID: 30989372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can Biomarkers Help the Early Diagnosis of Parkinson's Disease?
    Le W; Dong J; Li S; Korczyn AD
    Neurosci Bull; 2017 Oct; 33(5):535-542. PubMed ID: 28866850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T Lymphocytes in Parkinson's Disease.
    Contaldi E; Magistrelli L; Comi C
    J Parkinsons Dis; 2022; 12(s1):S65-S74. PubMed ID: 35253782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinson's disease biomarkers based on α-synuclein.
    Fayyad M; Salim S; Majbour N; Erskine D; Stoops E; Mollenhauer B; El-Agnaf OMA
    J Neurochem; 2019 Sep; 150(5):626-636. PubMed ID: 31265130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of innate immunity and inflammation in Parkinson´s disease.
    Öberg M; Fabrik I; Fabrikova D; Zehetner N; Härtlova A
    Scand J Immunol; 2021 May; 93(5):e13022. PubMed ID: 33471378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence of inflammatory system involvement in Parkinson's disease.
    Chao Y; Wong SC; Tan EK
    Biomed Res Int; 2014; 2014():308654. PubMed ID: 25050341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomics in Parkinson's disease: An unbiased approach towards peripheral biomarkers and new therapies.
    Alberio T; Fasano M
    J Biotechnol; 2011 Dec; 156(4):325-37. PubMed ID: 21925549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The search for biomarkers in Parkinson's disease: a critical review.
    Antoniades CA; Barker RA
    Expert Rev Neurother; 2008 Dec; 8(12):1841-52. PubMed ID: 19086880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced Activated T Lymphocytes (CD4+CD25+) and Plasma Levels of Cytokines in Parkinson's Disease.
    Rocha NP; Assis F; Scalzo PL; Vieira ÉLM; Barbosa IG; de Souza MS; Christo PP; Reis HJ; Teixeira AL
    Mol Neurobiol; 2018 Feb; 55(2):1488-1497. PubMed ID: 28176275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.